• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of vascular access for haemodialysis on patient morbidity and mortality.

作者信息

Woods J D, Port F K

出版信息

Nephrol Dial Transplant. 1997 Apr;12(4):657-9. doi: 10.1093/ndt/12.4.657.

DOI:10.1093/ndt/12.4.657
PMID:9140989
Abstract
摘要

相似文献

1
The impact of vascular access for haemodialysis on patient morbidity and mortality.血液透析血管通路对患者发病率和死亡率的影响。
Nephrol Dial Transplant. 1997 Apr;12(4):657-9. doi: 10.1093/ndt/12.4.657.
2
Complications associated with hemodialysis vascular access procedures: the case for a classification.与血液透析血管通路手术相关的并发症：一种分类方法
J Vasc Access. 2008 Jan-Mar;9(1):10-1.
3
Stenosis and thrombosis in haemodialysis fistulae and grafts: the radiologist's point of view.
Nephrol Dial Transplant. 2004 Feb;19(2):306-8. doi: 10.1093/ndt/gfg503.
4
Complications of the vascular access for hemodialysis.血液透析血管通路的并发症。
Contrib Nephrol. 2004;142:193-215. doi: 10.1159/000074862.
5
Stenosis and thrombosis in haemodialysis fistulae and grafts: the surgeon's point of view.血液透析动静脉内瘘和移植物的狭窄与血栓形成：外科医生的观点。
Nephrol Dial Transplant. 2004 Feb;19(2):309-11. doi: 10.1093/ndt/gfg504.
6
Systemic barriers to vascular access care: implications for clinical outcomes.血管通路护理的系统性障碍：对临床结局的影响
Contrib Nephrol. 2004;142:350-62. doi: 10.1159/000074851.
7
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.慢性肾脏病、终末期肾病以及透析第一年的发病率和死亡率状况。
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809.
8
[Vascular access for haemodialysis: an unresolved issue].[血液透析的血管通路：一个未解决的问题]
Nefrologia. 2010;30(3):280-7. doi: 10.3265/Nefrologia.pre2010.Apr.10349.
9
Advances in end-stage renal diseases 2000. Access monitoring methods.
Blood Purif. 2000;18(4):255-9. doi: 10.1159/000014445.
10
[Diagnosis and treatment of patients with ischemia of the upper extremities caused by a dialysis shunt].
Dtsch Med Wochenschr. 2003 Nov 28;128(48):2543-6. doi: 10.1055/s-2003-44945.

引用本文的文献

1
An Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients.平均血小板体积/血小板计数比值升高与血液透析患者血管通路失败相关。
PLoS One. 2017 Jan 17;12(1):e0170357. doi: 10.1371/journal.pone.0170357. eCollection 2017.
2
Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.系统性红斑狼疮所致终末期肾病患者与其他病因所致终末期肾病患者血管通路结局的比较：一项回顾性队列研究。
BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.
3
Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
开始使用带隧道的透析导管进行血液透析的患者，在动静脉内瘘和动静脉移植物建立后的生存率相似。
J Vasc Surg. 2015 Dec;62(6):1590-7.e2. doi: 10.1016/j.jvs.2015.07.076. Epub 2015 Sep 12.
4
Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.美国狼疮性肾炎继发终末期肾病患者与其他病因所致终末期肾病患者的医疗质量指标比较。
BMC Nephrol. 2015 Mar 29;16:39. doi: 10.1186/s12882-015-0037-1.
5
Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.美国狼疮性肾炎终末期肾病患者的医疗质量的社会人口统计学和地理预测因素。
Arthritis Rheumatol. 2015 Mar;67(3):761-72. doi: 10.1002/art.38983.
6
Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial.噻氯匹定预防血液透析患者原发性动静脉内瘘失败的随机对照试验。
J Renal Inj Prev. 2013 Sep 1;2(3):109-11. doi: 10.12861/jrip.2013.35. eCollection 2013.
7
The association between geographic proximity to a dialysis facility and use of dialysis catheters.地理上接近透析中心与使用透析导管之间的关联。
BMC Nephrol. 2014 Feb 27;15:40. doi: 10.1186/1471-2369-15-40.
8
Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation.在开始血液透析时，医疗证据报告和医疗保险索赔中报告的血管通路的一致性。
BMC Nephrol. 2014 Feb 8;15:30. doi: 10.1186/1471-2369-15-30.
9
Timing of arteriovenous fistula placement and Medicare costs during dialysis initiation.动静脉瘘管放置时机与透析起始时的医疗保险费用。
Am J Nephrol. 2012;35(6):498-508. doi: 10.1159/000338518. Epub 2012 May 11.
10
Statin therapy is not associated with improved vascular access outcomes.他汀类药物治疗与改善血管通路结局无关。
Clin J Am Soc Nephrol. 2010 Aug;5(8):1447-50. doi: 10.2215/CJN.02740310. Epub 2010 May 27.